A detailed history of Alpha Mark Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 500 shares of BSX stock, worth $45,215. This represents 0.01% of its overall portfolio holdings.

Number of Shares
500
Previous 500 -0.0%
Holding current value
$45,215
Previous $39,000 7.69%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 09, 2019

BUY
$32.91 - $40.75 $4,936 - $6,112
150 Added 42.86%
500 $19,000
Q1 2018

May 09, 2018

BUY
$25.2 - $28.54 $3,780 - $4,281
150 Added 75.0%
350 $10,000
Q3 2017

Nov 02, 2017

BUY
$26.26 - $29.17 $5,252 - $5,834
200
200 $6,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Alpha Mark Advisors, LLC Portfolio

Follow Alpha Mark Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Mark Advisors, LLC with notifications on news.